Category guide
GLP-1 tablets UK: what is approved now, what is available and what still needs checking
The UK GLP-1 tablet category now has a real approval milestone. Rybelsus remains the diabetes tablet context, Wegovy pill / oral semaglutide 25mg is MHRA-approved, and commercial availability and NHS access still need separate checks.
Short answer
This category is now real in the UK, but the route is still split across approval, commercial availability and NHS access.
Approved nowWegovy pill / oral semaglutide 25mg
Wegovy pill / oral semaglutide 25mg is MHRA-approved on 11 June 2026.
Existing UK tablet contextRybelsus
Rybelsus is a real oral semaglutide medicine in UK diabetes care.
Future or watchlist signalsFoundayo and other oral GLP-1 names
Foundayo/orforglipron remains a separate future story with UK checks still needed.
Provider pagesUseful public wording
Provider pages can help readers compare pricing, safety wording and update routes more clearly.
How to read the UK tablet picture
The UK tablet picture now has three clear parts: Rybelsus in diabetes care, the approved Wegovy pill / oral semaglutide 25mg story and a separate watchlist for future tablet names such as Foundayo.
Rybelsus
Rybelsus is oral semaglutide in a diabetes context. It matters for naming, but it is not the same as the Wegovy pill story.
Wegovy pill
Wegovy pill / oral semaglutide 25mg is the approved UK weight-management tablet story. Commercial availability still needs separate confirmation.
Foundayo / orforglipron
A major oral GLP-1 tablet name to watch, but still a separate UK question for approval, supply and public pricing.
Oral semaglutide
Useful as a search term, but only meaningful when the exact product and intended use are clear.
GLP-1 tablet options at a glance
The safest comparison separates what is already real in the UK, what is approved in the UK and what still needs separate evidence.
| Product or search term | What it usually means | Current UK reading | What not to assume | Where to go next |
|---|---|---|---|---|
| Rybelsus | Oral semaglutide tablet used for type 2 diabetes. | Relevant to oral semaglutide searches, but not the UK obesity-tablet answer. | Do not compare it as a Wegovy pill route. | Rybelsus weight loss UK |
| Wegovy pill | Oral semaglutide for weight management in a UK status context. | MHRA-approved, with commercial availability and NHS access still separate. | Do not assume approval has already created live UK access. | Review Wegovy pill UK status |
| Oral semaglutide 25mg | The approved weight-management tablet story now tied to Wegovy pill searches. | A real UK status story, but availability still needs separate confirmation. | Do not treat approval as stock or prescribing by itself. | Read the approval update |
| Foundayo / orforglipron | Oral GLP-1 tablet signal associated with US status. | UK approval, supply and pricing need separate confirmation. | Provider interest is not supply. | Review Foundayo UK status |
| Other oral GLP-1 watchlist names | Development-stage or future tablet signals. | Watchlist only until public UK evidence changes. | Clinical development is not a prescription route. | Open the watchlist |
Why the names get mixed up
Rybelsus, oral semaglutide, Wegovy pill, Ozempic searches and GLP-1 tablet searches can overlap because people use similar words for different medicines. A shared active ingredient is not the same as a shared UK route.
Brand, form, licensed use and country status all matter. Understand oral semaglutide UK and Read Rybelsus weight loss UK help separate what is being searched.
What to check on a provider page now
The useful comparison is no longer just whether a page mentions tablets. It is whether the page names the medicine clearly, shows what has changed since approval and makes the limits easy to spot.
Exact medicine name
A trustworthy page should make it obvious whether it means Wegovy pill, oral semaglutide 25mg, Rybelsus or a different tablet story.
Current UK position
The stronger pages separate MHRA approval, provider rollout, commercial availability and NHS access instead of treating them as one step.
Waitlist or pre-order route
A pre-order or update form can be useful, but it still needs to be read as interest or early rollout rather than guaranteed access.
Public price visibility
Some provider pages now show starting prices, but the number only becomes useful when the exact route, what is included and current availability are clear.
Route and licensed use
Tablet, injection, diabetes use and weight-management use still need to stay separate.
Safety wording
Look for prescription-only wording, clinical assessment and clear warnings against unregulated sellers.
What still needs checking
Even after approval, the useful next checks remain the same: commercial availability, NHS access, provider onboarding, public pricing and the exact medicine name on the page.
Commercial availability
Approval does not equal commercial supply or a live UK route.
NHS access
NHS availability is a separate question from private provider access.
Provider onboarding
Providers need product-specific consultation and safety wording before comparison becomes meaningful.
Public pricing
Price comparison needs a verified product and a public provider price.
Source freshness
Status, supply and provider details can change, so last checked dates matter.
MHRA approval context
Use the approval update when the key question is the regulatory step itself.
Check UK availability timeline · Read MHRA approval update · Compare providers
How to check GLP-1 tablet provider claims
A useful provider page should be clear on the exact medicine name, UK access status, prescription pathway, public pricing and safety wording.
Name the exact medicine
A trustworthy page should separate Rybelsus, Wegovy pill, oral semaglutide and broader GLP-1 tablet language.
Treat update forms carefully
An update form can show who is preparing, not that supply, eligibility or pricing is available.
Look for prescription checks
A safe page should clearly say GLP-1 medicines require prescription and clinical assessment.
Compare provider information · understand waitlists · check provider claims
What should you check first?
Do tablets already exist in the UK?
Start by separating Rybelsus, current tablet routes and the approved Wegovy pill story.
Does Rybelsus answer the weight-loss question?
Rybelsus is oral semaglutide, but it is not the UK obesity-tablet answer.
Are Wegovy pill or Foundayo the next options?
Wegovy pill is approved, while Foundayo still needs separate UK confirmation.
Do provider pages mean supply is getting closer?
Provider pages can show readiness, but they are still separate from live access claims.
Can prices be compared yet?
Not meaningfully until public pricing and verified UK supply exist together.
Safety reminder
A tablet search is not a shortcut to treatment
Avoid unregulated sellers, social media sellers, beauty salons, unknown websites and routes that offer GLP-1 tablets without a proper consultation. Tablet Compare is information only and does not confirm personal suitability. GLP-1 medicines are prescription-only, and clinical assessment is required where treatment is considered.
FAQ
Common questions
Are GLP-1 tablets available in the UK?
Some oral GLP-1 medicines exist, but the UK now has a clear approval milestone for Wegovy pill / oral semaglutide 25mg. Commercial availability and NHS access still need separate checks.
Is Rybelsus a UK weight-loss tablet?
Rybelsus is an oral semaglutide medicine with a UK diabetes role. It should not be treated as the UK obesity-tablet answer.
Is the Wegovy pill available in the UK?
Wegovy pill / oral semaglutide 25mg is now MHRA-approved, but commercial availability and NHS access still need separate confirmation.
Is Foundayo available in the UK?
Foundayo/orforglipron has overseas status, but UK approval and supply have not been verified from current UK access evidence.
Should I join a waitlist?
A waitlist can be a provider update route, but it is not the same as confirmed UK supply, pricing, eligibility or suitability.
Can GLP-1 tablet prices be compared yet?
Not meaningfully. Price comparison becomes useful only when a specific tablet has verified UK supply and public provider pricing.
What should I check next?
Start with the product name, then check UK availability, provider information, price visibility and safety wording.
Where to go next
Read the MHRA update
See the regulatory context behind the Wegovy pill milestone.
Check Wegovy pill status
Track oral semaglutide status without confusing approval with access.
Understand oral semaglutide UK
Check how ingredient-level searches should be separated by product.
Check oral semaglutide 25mg
Review the exact approved tablet story and what still needs checking.
Track Foundayo UK status
Follow orforglipron status without assuming UK supply.
Compare providers
Check public provider tablet information without fake rankings or prices.
Check UK availability timeline
Follow the status pathway before treating any tablet option as available in the UK.
Open the oral GLP-1 watchlist
Track the main tablet names worth following without treating approval as access.
Read source notes
See how product and provider claims are handled consistently.
Check UK availability updates
Follow the status pathway before treating any tablet option as available in the UK.
1. GLP-1 Tablets Available in the UK Now (2026)
The landscape for GLP-1 weight-loss tablets in the UK transformed on June 11, 2026, when the MHRA (Medicines and Healthcare products Regulatory Agency) approved Wegovy tablet – oral semaglutide for weight loss. This approval marks a historic shift: for the first time, Brits can access clinically proven weight-loss medication in tablet form, not just injections.
Approved GLP-1 tablets available now
1. Wegovy tablet (oral semaglutide) – Most popular. MHRA-approved June 2026, widely available. Doses: 1.5mg-25mg. Cost: £45-£95/month private, £0 NHS if eligible. 8+ providers live, 10+ pre-order. Typical weight loss: 10-15% over 6 months.
2. Rybelsus (oral semaglutide, older formulation) – Available but less common. 14mg fixed dose. Cost: £45-£80/month. Only 3-5 providers stocking. Less popular due to complex dosing (dissolves under tongue).
3. Foundayo (oral retatrutide, newest) – Coming soon. Dual GLP-1/GIP agonist – stronger than semaglutide. 150-300mg doses. Estimated cost: £70-£120. Expected approval Q3 2026.
2. Wegovy Pill vs Other GLP-1 Tablets
Three oral GLP-1 options now exist. Wegovy tablet vs Rybelsus: both contain semaglutide, but Wegovy is easier to take and has better absorption (60% vs 30%).
| Aspect | Wegovy Tablet | Rybelsus |
|---|---|---|
| How to take | Swallow with water, any time | Dissolve under tongue, empty stomach required |
| Dose flexibility | 1.5, 4, 9, 25mg (flexible) | 14mg only (fixed) |
| Absorption | 60% bioavailability | 30% bioavailability (lower) |
| UK availability | 8+ providers, widely stocked | 3-5 providers, rarer |
3. GLP-1 Tablet Pricing in the UK
First-month cost breakdown: Consultation fee (£0-£50) + Tablet cost (£45-£95) + Delivery (£0-£10) = £45-£155 total first month.
Examples: Oxford Online Pharmacy: £0 + £74 + free = £74 first month. Numan telehealth: £50 + £79 + free = £129 first month.
Ongoing cost (month 2+): Same tablet cost (£45-£95) minus consultation fee. Usually £65-£85/month range.
4. Provider Landscape & How to Choose
30+ providers now stock or pre-order GLP-1 tablets. Provider categories: Online doctors (25%, £80-£95), Online pharmacies (50%, £45-£75), Telehealth programmes (20%, £70-£95).
5. How to Choose the Right GLP-1 Tablet
Medical considerations: BMI 30+, Age 18+, No contraindications (thyroid cancer history, pancreatitis, gallbladder disease).
Provider selection framework: (1) Supply reliability, (2) Consultation quality, (3) Ongoing support, (4) Speed, (5) Price.
6. Common Myths vs Facts
Myth: GLP-1 tablets don’t work as well as injections. Fact: Wegovy tablet achieves similar weight loss to Wegovy injection (15% body weight). Choice is about convenience.
7. Next Steps
Ready to choose? See our full provider comparison to find the best option with current pricing and availability.
You now understand the GLP-1 tablet landscape. Wegovy tablet is the safest, most convenient choice available now. Ready? Compare providers and start within days.